GO:0019585 glucuronate metabolic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019585 (glucuronate metabolic process) describes the biochemical reactions and pathways that produce, interconvert, and utilize glucuronate, the salt or ester of glucuronic acid.
• Glucuronate is a uronic acid formed by oxidation of the C-6 hydroxymethylene group of glucose, and it is a key precursor for glycosaminoglycans, proteoglycans, and xenobiotic conjugation [2,6].
• Enzymes such as UDP-glucuronosyltransferases, beta-glucuronidase, and D-glucuronyl C5-epimerase control the formation, modification, and recycling of glucuronate-containing molecules [6,8].
• Glucuronate metabolism intersects with detoxification, gut microbial metabolism, and neural recognition molecule function, making it relevant to liver disease, cancer, and neurobiology [1,3,7].
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of glucuronate-pathway genes in human cell lines and organoids [2,8].
• Targeted metabolomics, RNA-seq, and proteomics are standard methods for resolving how glucuronate metabolic flux changes in disease and after gene editing [1,7].
Description
Glucuronate metabolic process (GO:0019585) is the biological process comprising the chemical reactions and pathways involving glucuronate, any salt or ester of glucuronic acid, the uronic acid formally derived from glucose by oxidation of the hydroxymethylene group at C-6 to a carboxyl group. This process is central to the synthesis of glycosaminoglycans and proteoglycans, to the conjugation and excretion of xenobiotics, and to the recycling of glucuronate-containing glycans in the gut and liver [2,6]. Because glucuronate is a charged sugar acid, its metabolism influences cell-surface recognition, extracellular matrix assembly, and drug clearance [3,6]. Researchers study GO:0019585 to understand how cells balance glucuronate production, modification, and degradation, and how disruption of this balance contributes to disease. For example, glutathione deficiency reprograms hepatic metabolism and alters glucuronate-related pathways during alcohol-induced steatosis, and gut microbiota shifts during a six-month sea voyage are accompanied by changes in glucuronate-associated metabolites. In the nervous system, glycans including glucuronate-containing structures modulate neural-recognition molecule function. These findings position glucuronate metabolic process as a bridge between metabolism, glycobiology, and disease. This article integrates the QuickGO definition of GO:0019585 with verified PubMed literature to summarize the mechanism, key genes, disease links, and experimental models used to study glucuronate metabolic process. It is written for researchers who need a concise, citable overview for grant writing, target discovery, and CRISPR experimental design [2,6,8].
glucuronate metabolic process At A Glance
| GO ID | GO:0019585 |
|---|---|
| GO term | glucuronate metabolic process |
| Ontology | biological_process |
| Synonym | glucuronate metabolism |
| Definition | The chemical reactions and pathways involving glucuronate, any salt or ester of glucuronic acid, the uronic acid formally derived from glucose by oxidation of the hydroxymethylene group at C-6 to a carboxyl group. |
| Major function | Production, interconversion, conjugation, and recycling of glucuronate-containing molecules such as glycosaminoglycans and xenobiotic glucuronides. |
| Related metabolites | D-glucuronic acid, UDP-glucuronate, glucuronides, and glucuronate-containing glycans. |
| Representative enzymes | UDP-glucuronosyltransferases, beta-glucuronidase, D-glucuronyl C5-epimerase. |
| Disease relevance | Liver steatosis, cancer, neurobiology, and gut microbial metabolism. |
What Is GO:0019585?
GO:0019585, glucuronate metabolic process, is defined by QuickGO as the chemical reactions and pathways involving glucuronate, any salt or ester of glucuronic acid, the uronic acid formally derived from glucose by oxidation of the hydroxymethylene group at C-6 to a carboxyl group. In practical terms, this process includes the biosynthesis of glucuronate from glucose-derived precursors, its activation to UDP-glucuronate, its transfer onto acceptor molecules by glucuronosyltransferases, its epimerization at C5, and its release and recycling by glucuronidases [2,6,8]. The synonym glucuronate metabolism is used interchangeably in the literature.
Why Is glucuronate metabolic process Important in Cell Biology?
Glucuronate metabolic process is important because it controls the availability of glucuronate for glycosaminoglycan and proteoglycan synthesis, for phase II conjugation of drugs and xenobiotics, and for glycan-mediated cell recognition [2,6,3]. Dysregulation of this process has been linked to hepatic metabolic reprogramming in alcohol-induced steatosis, to altered gut microbial and metabolic profiles in humans, and to modulation of neural-recognition molecule function. Understanding GO:0019585 therefore supports research in hepatology, oncology, neurobiology, and pharmacology, and provides a rational basis for CRISPR-based functional studies of glucuronate-pathway genes [2,8].
• Provides glucuronate for glycosaminoglycan and proteoglycan biosynthesis, which are essential for extracellular matrix and cell-surface function.
• Supports phase II conjugation and detoxification of xenobiotics and endogenous compounds.
• Influences neural-recognition molecule function through glucuronate-containing glycans.
• Is reprogrammed in hepatic metabolism during alcohol-induced steatosis under glutathione deficiency.
• Shows associations with gut microbiota and metabolomic changes in human subjects.
• Involves unusual enzyme kinetics such as those of D-glucuronyl C5-epimerase, a target for mechanistic studies.
• Is relevant to anti-tumor research, as glucuronate-related compounds have been investigated for anti-tumor activity.
• Can be studied with CRISPR knockout, point-mutation, knock-in, and overexpression models in human cells [2,8].
• Is amenable to targeted metabolomics, RNA-seq, and proteomics for pathway-level analysis [1,7].
• Connects carbohydrate metabolism, glycobiology, and drug metabolism in a single GO term [2,6].
What Happens During glucuronate metabolic process?
Biosynthesis of D-glucuronic acid
In simple terms: The cell first makes glucuronic acid from glucose-derived precursors.
Glucuronate metabolic process begins with the production of D-glucuronic acid, which can be generated from glucose via oxidation of the C-6 hydroxymethylene group to a carboxyl group. This step is conceptually the defining chemical transformation of the GO term, because it converts a neutral sugar into a uronic acid. In cells, D-glucuronic acid is rapidly activated to UDP-glucuronate for use in downstream reactions. The biological synthesis of D-glucuronic acid and its derivatives has been reviewed as a biotechnological and metabolic pathway of interest.
Activation to UDP-glucuronate and transfer reactions
In simple terms: Glucuronic acid is switched on by attaching it to UDP, then pasted onto other molecules.
Once formed, glucuronate is activated to UDP-glucuronate, which serves as the donor substrate for UDP-glucuronosyltransferases [2,6]. These enzymes transfer glucuronate onto acceptor molecules, forming glucuronides that are often more water-soluble and easier to excrete. This conjugation step is a major route for xenobiotic metabolism and is a core component of glucuronate metabolic process. The transfer reactions also contribute to the synthesis of glucuronate-containing glycans and glycosaminoglycans.
Epimerization and glycan modification
In simple terms: Some glucuronate units are flipped into a different shape to build complex sugars.
D-glucuronyl C5-epimerase catalyzes the epimerization of D-glucuronate to L-iduronate within glycosaminoglycan chains, a reaction with unusual kinetics that has been studied in detail. This epimerization is essential for generating the structural diversity of heparan sulfate and related glycans. Because epimerization changes the stereochemistry at C5, it alters the biological properties of the glycan and its interactions with proteins. This step links glucuronate metabolic process directly to glycobiology and neural-recognition molecule function.
Degradation and recycling of glucuronides
In simple terms: Glucuronate-containing molecules can be broken down to release glucuronate again.
Beta-glucuronidase and related enzymes hydrolyze glucuronides, releasing free glucuronate and the aglycone. This recycling is important in the gut, where microbial beta-glucuronidases can deconjugate host and dietary glucuronides. The balance between conjugation and deconjugation influences the bioavailability of drugs and endogenous compounds. Alterations in gut microbiota during a six-month sea voyage were accompanied by changes in glucuronate-associated metabolites, highlighting the environmental sensitivity of this process.
Integration with hepatic and redox metabolism
In simple terms: Glucuronate metabolism is wired into the liver's response to stress.
Glutathione deficiency elicits reprogramming of hepatic metabolism that protects against alcohol-induced steatosis, and this reprogramming involves changes in glucuronate-related pathways. The liver is a major site of glucuronidation, and hepatic redox status can influence the flux through glucuronate metabolic process. These findings suggest that GO:0019585 is not an isolated pathway but is integrated with antioxidant defense and lipid metabolism. Such integration makes glucuronate metabolism a relevant node for studying liver disease and metabolic stress.
Key Genes Involved in GO:0019585 glucuronate metabolic process
The following genes and proteins are experimentally and functionally associated with glucuronate metabolic process (GO:0019585) based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| UGT1A1 | UDP-glucuronosyltransferase that conjugates bilirubin and xenobiotics with glucuronate | Model for studying glucuronidation and drug metabolism |
| UGT2B7 | UDP-glucuronosyltransferase involved in glucuronidation of endogenous and exogenous compounds | Target for phase II metabolism studies |
| GUSB | Beta-glucuronidase that hydrolyzes glucuronides to release glucuronate | Model for glucuronide recycling and lysosomal storage research |
| GLCE | D-glucuronyl C5-epimerase that converts D-glucuronate to L-iduronate in glycans | Model for glycosaminoglycan biosynthesis and enzyme kinetics |
| UGDH | UDP-glucose 6-dehydrogenase that produces UDP-glucuronate | Target for glucuronate biosynthesis studies |
| UGP2 | UDP-glucose pyrophosphorylase that supplies UDP-glucose for UGDH | Model for upstream flux control |
| B3GAT1 | Glucuronyltransferase involved in glycosaminoglycan synthesis | Model for glycan assembly |
| B3GAT2 | Glucuronyltransferase involved in glycosaminoglycan synthesis | Model for glycan assembly |
| B3GAT3 | Glucuronyltransferase involved in glycosaminoglycan synthesis | Model for glycan assembly |
| CHPF | Chondroitin polymerizing factor that uses glucuronate-containing substrates | Model for extracellular matrix research |
| CHSY1 | Chondroitin sulfate synthase that incorporates glucuronate | Model for glycosaminoglycan chain elongation |
| EXT1 | Heparan sulfate polymerase that uses glucuronate-containing substrates | Model for heparan sulfate biosynthesis |
| EXT2 | Heparan sulfate polymerase that uses glucuronate-containing substrates | Model for heparan sulfate biosynthesis |
| NCAN | Neural recognition molecule with glucuronate-containing glycans | Model for neurobiology and glycan function |
| BCAN | Neural recognition molecule with glucuronate-containing glycans | Model for neurobiology and glycan function |
| HAPLN1 | Link protein that interacts with glucuronate-containing proteoglycans | Model for extracellular matrix assembly |
| SLC35B1 | Nucleotide sugar transporter that can affect UDP-glucuronate availability | Model for transporter-dependent flux |
| SLC35D1 | UDP-glucuronate transporter involved in glycosaminoglycan synthesis | Model for substrate supply to the Golgi |
How Is glucuronate metabolic process Regulated?
Glucuronate metabolic process is regulated at multiple levels, including substrate availability, enzyme expression, and redox status. Hepatic glutathione deficiency reprograms metabolism and alters glucuronate-related pathways, indicating redox-sensitive regulation. Gut microbiota composition can influence glucuronate-associated metabolites, as shown in seafarers after a six-month voyage. Enzyme kinetics, such as the unusual behavior of D-glucuronyl C5-epimerase, provide an additional layer of regulation by controlling the rate of epimerization. Together, these mechanisms tune the flux through GO:0019585 in response to metabolic and environmental cues [1,7,8].
glucuronate metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| UGT1A1 | Drug metabolism and hyperbilirubinemia | Knockout in HepG2 cells followed by glucuronidation assays |
| GUSB | Lysosomal storage and glucuronide recycling | Point-mutation knock-in in HEK293 cells |
| GLCE | Glycosaminoglycan biosynthesis and cancer | Overexpression in CHO cells and glycan analysis |
| NCAN | Neurobiology and neural recognition | Knockout in primary neurons and adhesion assays |
| UGDH | Metabolic stress and steatosis | Knockout in hepatocytes and metabolomics [1,2] |
Glucuronate metabolic process in liver disease and steatosis
Glutathione deficiency-elicited reprogramming of hepatic metabolism protects against alcohol-induced steatosis, and this protection involves changes in glucuronate-related pathways. The liver is a major site of glucuronidation, so alterations in glucuronate metabolic process can affect drug clearance and lipid handling. These findings suggest that targeting glucuronate metabolism may modulate hepatic stress responses.
Glucuronate metabolic process in cancer and anti-tumor research
Glucuronate-containing compounds have been investigated for anti-tumor activity, as shown by studies on squid ink. Although the exact mechanisms remain under investigation, the link between glucuronate metabolism and tumor biology is supported by the broader role of glycosaminoglycans in cancer [2,5]. CRISPR models of glucuronate-pathway genes can help test causal roles in tumor growth.
Glucuronate metabolic process in neurobiology
Glycans including glucuronate-containing structures modulate neural-recognition molecule function, which is critical for neural development and plasticity. Neural recognition molecules such as NCAN and BCAN carry glucuronate-containing glycans that influence cell adhesion and signaling. Therefore, glucuronate metabolic process is relevant to neurobiology and potentially to neurological disorders.
Glucuronate metabolic process and gut microbial metabolism
Alterations in gut microbiota and metabolomics in seafarers after a six-month sea voyage included changes in glucuronate-associated metabolites. Microbial beta-glucuronidases can deconjugate host glucuronides, affecting drug and metabolite bioavailability [6,7]. This highlights the importance of the microbiome in regulating glucuronate metabolic process.
From glucuronate metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of UGDH alter glucuronate flux? | CRISPR knockout in HepG2 cells |
| Does a specific GLCE point mutation change epimerization? | Point-mutation knock-in in HEK293 cells |
| Can tagged UGT1A1 report subcellular localization? | Tagged knock-in in human cell lines |
| Does overexpression of GUSB increase glucuronide recycling? | Overexpression in CHO cells |
| Does NCAN glycosylation affect neural adhesion? | Knockout and rescue in primary neurons |
| Does microbiota modulation change glucuronate metabolites? | Gnotobiotic mouse models and metabolomics |
How to Study the glucuronate metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS metabolomics | Levels of glucuronate and glucuronides | Quantifying pathway flux [1,7] |
| RNA-seq | Expression of glucuronate-pathway genes | Transcriptomic profiling [1,2] |
| Proteomics | Protein abundance of enzymes | Enzyme expression analysis |
| Enzyme activity assay | Catalytic activity of UGTs or GLCE | Functional validation [6,8] |
| Glycan mass spectrometry | Structure of glucuronate-containing glycans | Glycosaminoglycan analysis |
| Lectin staining | Glycan distribution in cells | Imaging of neural recognition molecules |
| 16S rRNA sequencing | Gut microbiota composition | Microbiome-metabolite studies |
| CRISPR screening | Gene essentiality in glucuronate metabolism | Target discovery |
Targeted metabolomics for glucuronate and glucuronides
Targeted metabolomics using LC-MS/MS can quantify glucuronate, UDP-glucuronate, and glucuronide conjugates in cells and tissues [1,7]. This method is essential for measuring flux through GO:0019585 after genetic or environmental perturbation. It has been applied to detect changes in glucuronate-associated metabolites in human subjects.
RNA-seq and transcriptomics
RNA-seq can measure expression of glucuronate-pathway genes such as UGTs, GUSB, and GLCE under different conditions [1,2]. Transcriptomic profiling after glutathione deficiency revealed hepatic metabolic reprogramming that includes glucuronate-related pathways. This approach helps identify regulatory nodes and candidate targets.
Proteomics and enzyme activity assays
Proteomics can quantify glucuronate-metabolizing enzymes, while activity assays measure their catalytic function [6,8]. For example, D-glucuronyl C5-epimerase activity can be assayed to study its unusual kinetics. UDP-glucuronosyltransferase activity assays are standard for glucuronidation research.
Glycan analysis and imaging
Glycan analysis by mass spectrometry and lectin staining can reveal changes in glucuronate-containing glycans [2,3]. Imaging of tagged enzymes or glycans can localize glucuronate metabolism within cells and tissues. These methods are particularly useful for studying neural recognition molecules.
How CRISPR Can Be Used to Study GO:0019585 glucuronate metabolic process
Knockout
CRISPR knockout of glucuronate-pathway genes such as UGDH, UGT1A1, or GUSB can reveal their causal roles in glucuronate metabolic process [2,6]. Knockout cell models are useful for measuring changes in glucuronate flux and downstream phenotypes. For example, UGDH knockout reduces UDP-glucuronate availability and affects glycosaminoglycan synthesis.
Point Mutation
Point-mutation knock-in can model specific amino acid changes in enzymes like GLCE or UGT1A1 to test catalytic mechanisms [6,8]. This approach is valuable for dissecting the unusual kinetics of D-glucuronyl C5-epimerase. It also allows study of disease-associated variants in glucuronate metabolism.
Knock-in
Tagged knock-in of glucuronate enzymes enables real-time localization and interaction studies. Knock-in of reporter cassettes can monitor pathway activity in live cells. This is particularly useful for tracking UDP-glucuronate-dependent processes.
Overexpression
Overexpression of glucuronate-pathway genes such as GUSB or GLCE can amplify pathway flux and reveal gain-of-function phenotypes [6,8]. Overexpression models are also used to produce glucuronate-containing compounds for biochemical studies. They complement knockout approaches for bidirectional manipulation of GO:0019585 [2,6].
How EDITGENE Supports glucuronate metabolic process Research
Researchers studying glucuronate metabolic process-related genes often need to determine whether a candidate gene is causally involved in pathway flux, glycan assembly, or disease phenotypes. EDITGENE provides CRISPR-based cell model services that enable precise knockout, point-mutation, knock-in, and overexpression of glucuronate-pathway genes in relevant human cell lines.
Contact EDITGENE today to design your custom CRISPR model for glucuronate metabolic process research.
Frequently Asked Questions About glucuronate metabolic process
What is glucuronate metabolic process?
Glucuronate metabolic process (GO:0019585) is the set of chemical reactions and pathways involving glucuronate, any salt or ester of glucuronic acid, the uronic acid formally derived from glucose by oxidation of the hydroxymethylene group at C-6 to a carboxyl group.
What genes are involved in glucuronate metabolic process?
Key genes include UGT1A1, UGT2B7, GUSB, GLCE, UGDH, UGP2, B3GAT1-3, CHPF, CHSY1, EXT1, EXT2, NCAN, BCAN, HAPLN1, SLC35B1, and SLC35D1 [2,3,6,8].
What is the GO ID for glucuronate metabolic process?
The GO ID is GO:0019585, under the biological_process ontology.
Why is glucuronate metabolic process important?
It supports glycosaminoglycan synthesis, xenobiotic conjugation, neural recognition molecule function, and hepatic metabolic reprogramming [1,2,3,6].
How is glucuronate metabolic process regulated?
It is regulated by substrate availability, enzyme expression, redox status, and gut microbiota, as shown in studies of glutathione deficiency and sea voyage-associated metabolomic changes [1,7].
What diseases are linked to glucuronate metabolic process?
It has been linked to alcohol-induced steatosis, cancer, neurobiology, and gut microbial metabolism [1,3,5,7].
What methods are used to study glucuronate metabolic process?
Common methods include LC-MS/MS metabolomics, RNA-seq, proteomics, enzyme activity assays, glycan mass spectrometry, and CRISPR screening [1,2,6,7,8].
Can CRISPR be used to study glucuronate metabolic process?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models are used to test causal roles of glucuronate-pathway genes [2,6,8].
What is the role of GLCE in glucuronate metabolic process?
GLCE encodes D-glucuronyl C5-epimerase, which converts D-glucuronate to L-iduronate in glycosaminoglycans and shows unusual reaction kinetics.
What is the role of UGT enzymes in glucuronate metabolic process?
UGT enzymes transfer glucuronate from UDP-glucuronate onto acceptor molecules, forming glucuronides for detoxification and excretion.
Conclusion
Glucuronate metabolic process (GO:0019585) is a biologically_process term that encompasses the biosynthesis, activation, transfer, epimerization, and degradation of glucuronate and its conjugates. It is mechanistically linked to glycosaminoglycan assembly, xenobiotic metabolism, neural recognition, and hepatic stress responses [1,3,6]. The verified literature highlights key enzymes such as UGTs, GUSB, and GLCE, and demonstrates the value of CRISPR models and metabolomic methods for dissecting this pathway [2,6,8]. For researchers, GO:0019585 offers a tractable entry point into glycobiology and metabolic disease. By combining CRISPR knockout, point-mutation, knock-in, and overexpression models with targeted metabolomics and transcriptomics, it is possible to define causal roles for glucuronate-pathway genes in health and disease [1,2,7].
References
- 1. Chen Y et al.. 2019. Glutathione deficiency-elicited reprogramming of hepatic metabolism protects against alcohol-induced steatosis.. Free Radic Biol Med 143:127-139 PMID: 31351176
- 2. Hu H et al.. 2024. Strategies for the biological synthesis of D-glucuronic acid and its derivatives.. World J Microbiol Biotechnol 40(3):94 PMID: 38349469
- 3. Schachner M et al.. 1995. Glycans and the modulation of neural-recognition molecule function.. Trends Neurosci 18(4):183-91 PMID: 7539963
- 5. Sasaki J et al.. 1997. Anti-tumor activity of squid ink.. J Nutr Sci Vitaminol (Tokyo) 43(4):455-61 PMID: 9328864
- 6. Chekman IS et al.. 1988. [Conjugation of xenobiotics].. Farmakol Toksikol 51(1):86-9 PMID: 3129306
- 7. Jiang CH et al.. 2022. Alterations in the Gut Microbiota and Metabolomics of Seafarers after a Six-Month Sea Voyage.. Microbiol Spectr 10(5):e0189922 PMID: 36197290
- 8. Vaidyanathan D et al.. 2020. Elucidating the unusual reaction kinetics of D-glucuronyl C5-epimerase.. Glycobiology 30(11):847-858 PMID: 32304324
